Data Errors in Results and Table 2

In the Original Investigation titled “Efficacy and Safety of Lumateperone for Treatment of Schizophrenia: A Randomized Clinical Trial” by Correll et al,¹ published online January 8, 2020, in the Efficacy subsection of the Results section, the multiplicity-adjusted P values for change from baseline to day 28 in the Positive and Negative Syndrome Scale total score vs placebo and for change from baseline to day 28 in the Clinical Global Impression–Severity of Illness were P = .04, not P = .05; this change has also been made to the corresponding data in Table 2. Furthermore, the nominal P values for these data were actually unadjusted. This article has been corrected online.